Login / Signup

Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review.

Ji-Won KimJu Yang JungChang-Hee Suh
Published in: Expert opinion on biological therapy (2020)
According to published data, the use of biosimilars for inflammatory arthritis led to no significant inferiority in treatment outcomes and resulted in considerable cost savings in the real-world. Currently, beyond the use of biosimilars, issues with the interchangeability of biosimilars, including immunogenicity, should be addressed. Strategies to overcome these concerns will improve treatment efficacy and safety in patients with inflammatory arthritis.
Keyphrases
  • rheumatoid arthritis
  • oxidative stress
  • systematic review
  • combination therapy
  • big data